Tetrahydroquinoline analogues for use in glaucoma treatment

作者: Ronald D. Schoenwald , Charles F. Barfknecht

DOI:

关键词: OptometryGlaucomaMedicine

摘要: Tetrahydroquinoline analogues and compositions containing them for topically treating glaucoma to effectively reduce intraocular eye pressure.

参考文章(21)
Christian Prunte, Rudolf Markstein, Ines Nuttli, Topical SDZ GLC-756, a novel dopamine D-1 antagonist and D-2 agonist, lowers intraocular pressure in conscious rabbits. Japanese Journal of Ophthalmology. ,vol. 40, pp. 167- 173 ,(1996)
Harriet W. Hamilton, William C. Patt, Tetrahydroisoquinoline-type renin inhibiting peptides ,(1991)
Hiroko Masamune, Lawrence S. Melvin, James F. Eggler, Anthony Marfat, Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases ,(1989)
Marion Dugdale, Ronald P. Quintana, Randy W. Johnson, Andrew Lasslo, Platelet aggregation inhibitory agents and intermediates therefor ,(1983)
Ronald D. Schoenwald, John L. Lach, Controlled release ophthalmic gel formulation ,(1986)
Nobuyuki Tanaka, Kazuyuki Nakagawa, Yoichi Nishinakamura, Compositions for treating glaucoma containing a carbostyril ,(1980)
Pierre Schelling, Ingeborg Lues, Klaus-Otto Minck, Werner Mederski, Norbert Beier, Dieter Dorsch, 2-oxoquinoline derivatives ,(1993)
Michel Dietz, Georges de Burlet, Guy Andermann, Beatrice Ruhland, Gerard LeClerc, Compounds having GABA like activity, and use of same in tissue irrigating solutions ,(1988)